LISDEXAMFETAMINE IN CANADA: A DETAILED GUIDE

Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in children and grown-ups . In Canada, its distribution is managed by Health Canada. This overview seeks to present understandable information on its indications, potential side